Assembly Biosciences (ASMB) Financials

$36.60

$0.47 (1.30%)

As on 04-Sep-2026 16:01EDT

Market cap

$745 Mln

Revenue (TTM)

$75 Mln

P/E Ratio

29.5

P/B Ratio

2.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	74.84	72.30	28.52	7.16	--	6.25
Cost of Revenue	16.67	0.13	55.93	48.90	0.50	0.47
Gross Profit	58.18	72.17	-27.41	-41.74	-0.50	6.25
Operating Expenses	67.04	84.42	18.01	22.91	94.11	138.94
Operating Profit (EBIT)	-8.80	-12.12	-45.42	-64.65	-94.11	-132.69
Other Income	--	--	--	--	1.02	--
Profit before Tax	-0.04	-6.12	-39.85	-61.20	-93.09	-132.39
Provision for Tax	--	--	0.33	0.03	-1.02	-2.53
Profit after Tax (Net Income)	-0.04	-6.12	-40.18	-61.23	-92.07	-129.86
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-93.09	-129.86

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	305.65	206.75	33.36	41.10	82.66	168.93
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.74	2.06	38.01	56.50	2.83	6.06
Current Liabilities	23.45	48.78	47.80	39.23	16.30	16.07
Total Liabilities	354.28	257.59	119.17	136.82	101.79	191.06

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	2.85	3.04	3.67	3.04	4.83	36.86
Current Assets	327.98	254.55	115.50	133.79	96.97	154.20
Total Assets	354.28	257.59	119.17	136.82	101.79	191.06
Total Debt*	2.35	2.63	3.09	2.34	3.47	6.48
Net Current Assets	304.53	205.77	67.70	94.56	80.67	138.13

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-41.09	-51.12	22.74	-84.46	-93.40
Cash Flow from Investing Activities	--	-113.47	40.17	-69.14	90.64	26.52
Cash from Financing Activities	--	174.67	29.45	13.82	0.61	53.06
Net Cash Inflow / Outflow	--	--	--	--	6.79	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	0.03	-0.55	-6.10	-11.17	-22.64	-28.50
Cash EPS ($)	--	-0.53	-6.09	-11.08	-22.52	-28.39
Adjusted Book Value ($)	--	18.44	5.07	7.50	20.33	37.07
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.67	-7.77	4.15	-20.77	-20.50
Free Cash Flow per Share ($)	--	-3.67	-7.77	4.10	-20.80	-21.17

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-4.98	-100.58	-94.51	-70.41	-60.95
ROE (%)	-0.02	-5.10	-107.92	-98.95	-73.19	-63.42
ROA (%)	-0.02	-3.25	-31.39	-51.32	-62.88	-54.75
EBIT Margin (%)	-0.06	-8.47	-139.72	-854.32	--	-1,455.87
Net Margin (%)	-0.06	-8.47	-140.87	-854.78	-9,008.81	-2,076.35
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	125.12	1.54	2.98	--	-1.00	-0.92
EBIT Growth (%)	99.89	84.64	34.89	34.98	-3.37	-54.08
Net Profit Growth (%)	99.89	84.76	34.38	33.50	29.10	-108.93
EPS Growth (%)	100.49	0.91	0.45	0.51	0.21	-0.82
Book Value Growth (%)	585.72	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	29.52	-62.28	-2.58	-0.07	-0.06	-0.08
Price / Book Value	2.41	1.84	3.11	0.11	0.06	0.06
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.42	-22.66	0.13	2.03	0.89	1.43
Close Price ($)	27.48	34.01	15.78	9.84	15.60	27.96
High Price ($)	39.71	39.71	19.93	21.36	29.40	84.24
Low Price ($)	16.90	7.75	9.12	7.69	9.84	24.36
Market Cap ($ Cr)	745.20	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	0.09	0.06	0.04	0.04
Short term debt to equity ratio	0.00	0.00	0.01	0.03	0.04	0.02
Current Ratio	13.99	5.22	2.42	3.41	5.95	9.59
Quick Ratio	13.99	--	--	3.49	5.95	9.59
Interest Coverage	--	--	--	--	-188.98	-1.10

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	1.10	1.35	1.40	0.60	--	5.37
Asset Turnover	0.31	0.38	0.22	0.06	--	0.03
Receivable days	--	3.47	2.84	25.16	--	45.73
Inventory Days	--	--	-20.88	-11.94	0.00	0.00
Payable days	--	2,485.97	3.42	11.03	1,889.33	2,844.01
Cash Conversion Cycle	--	--	-21.46	2.19	--	-2,798.28

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.